Methods Retrospective review of patients undergoing colonoscopy with polypectomy without
interruption of clopidogrel. Patients with lesions larger than 1cm were generally rescheduled …

Background: According to current practice guidelines, polypectomy is considered a high-risk
procedure for which antiplatelet medications such as clopidogrel should be discontinued for …

BACKGROUND: The risk of postpolypectomy bleeding (PPB) in patients undergoing
colonoscopy on uninterrupted clopidogrel therapy has not been established. OBJECTIVE …

Background We do not routinely discontinue clopidogrel before colonoscopy because we
have judged the cardiovascular risks of that practice to exceed the risks of post-polypectomy …

Background and study aims Optimal peri-colonoscopic management of clopidogrel remains
unclear. Cold snare polypectomy is safe and effective for removing polyps≤ 10 mm and …

Background & Aims Guidelines recommend withholding clopidogrel 7 days before
polypectomy to decrease bleeding risk, but these were written based on limited evidence …

Background Current guidelines recommend the cessation of clopidogrel therapy 5 days and
7–10 days prior to colonoscopic polypectomy. Recent studies have advocated for continued …

Current guidelines recommend temporary cessation of clopidogrel for 7‑10 days for patients
on clopidogrel undergoing colonoscopy with polypectomy. However, recent prospective …

Background Current guidelines recommend continuing aspirin and discontinuing
clopidogrel for colon polypectomy, but evidence for endoscopic mucosal resection (EMR) is …

Aim To determine whether antiplatelet agents affect the incidence of immediate and delayed
post-polypectomy bleeding. Methods Patients who had colonoscopic polypectomy at a …